# Lyell Immunopharma, Inc. (LYEL)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/LYEL/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 2.0K | $ -24.15M | $ -38.60M | $ 39.49M | $ 273.67M |
| 2025 | $ 36.9K | $ -281.01M | $ -154.41M | $ 41.92M | $ 248.20M |
| 2024 | $ 64.1K | $ -360.51M | $ -171.18M | $ 58.97M | $ 382.82M |
| 2023 | $ 140.6K | $ -253.70M | $ -179.90M | $ 63.17M | $ 654.95M |
| 2022 | $ 94.60M | $ -204.56M | $ -216.53M | $ 67.70M | $ 833.25M |
| 2021 | $ 12.66M | $ -297.42M | $ -227.88M | $ 67.82M | $ 929.79M |
| 2020 | $ 9.88M | $ -260.48M | $ -270.53M | $ 54.57M | $ 718.44M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.14 |
| Liabilities / Eq | 0.28 |
| Current Ratio | 7.23 |

## Other views

- [Metrics](https://sponda.capital/en/LYEL.md)
- [Charts](https://sponda.capital/en/LYEL/charts.md)
- [Compare](https://sponda.capital/en/LYEL/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.